{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:53:41Z","timestamp":1789851221958,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Cubist Pharmaceuticals"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ijantimicag.2014.01.007","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T20:00:17Z","timestamp":1391803217000},"page":"328-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":202,"title":["Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009\u20132012"],"prefix":"10.1016","volume":"43","author":[{"given":"Helio S.","family":"Sader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0885066610371189","article-title":"Empiric therapy for Gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind","volume":"25","author":"Arnold","year":"2010","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0010","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cid\/cit152","article-title":"10\u00d7\u201920 progress\u2014development of new drugs active against Gram-negative bacilli: an update from the Infectious Diseases Society of America","volume":"56","author":"Boucher","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2014.01.007_bib0015","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/653038","article-title":"Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia","volume":"51","author":"Sorbello","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1378\/chest.122.1.262","article-title":"Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia","volume":"122","author":"Iregui","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0025","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","article-title":"Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment","volume":"49","author":"Micek","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1378\/chest.111.3.676","article-title":"Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia","volume":"111","author":"Luna","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0035","first-page":"388","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"15","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2014.01.007_bib0040","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1086\/653049","article-title":"Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia","volume":"51","author":"Torres","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00134-008-1336-9","article-title":"Defining, treating and preventing hospital acquired pneumonia: European perspective","volume":"35","author":"Torres","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0050","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.diagmicrobio.2013.03.032","article-title":"Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007\u20132009 SENTRY Antimicrobial Surveillance Program","volume":"76","author":"Kaiser","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0055","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Document M07-A9","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0060","series-title":"Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. Document M100-S23","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0065","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 3.0; January 2013. http:\/\/www.eucast.org\/clinical_breakpoints\/ [accessed 02.01.13]."},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0070","unstructured":"Wyeth Pharmaceuticals Inc. Tygacil\u00ae package insert 2012. http:\/\/www.tygacil.com [accessed 31.01.13]."},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.diagmicrobio.2008.04.009","article-title":"Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia","volume":"61","author":"Tanaseanu","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2014.01.007_bib0080","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/653053","article-title":"Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia","volume":"51","author":"Jones","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkn162","article-title":"Guidelines for the management of hospital-acquired pneumonia in the UK: report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy","volume":"62","author":"Masterton","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0100","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jac\/dks084","article-title":"Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies","volume":"67","author":"Cai","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0105","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/jac\/dkr239","article-title":"Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006\u201309)","volume":"66","author":"Gales","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijantimicag.2010.10.005","article-title":"Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the SENTRY Antimicrobial Surveillance Program (2006\u20132009)","volume":"37","author":"Sader","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.diagmicrobio.2007.10.017","article-title":"Tigecycline activity tested against 11,808 bacterial pathogens recently collected from US medical centers","volume":"60","author":"Gales","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.ijantimicag.2014.01.007_bib0120","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1016\/S0924-8579(09)70005-6","article-title":"A review of tigecycline\u2014the first glycylcycline","volume":"32","author":"Peterson","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/mdr.2012.0238","article-title":"Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineages","volume":"19","author":"Castanheira","year":"2013","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2014.01.007_bib0130","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/AAC.02252-12","article-title":"Prevalence of \u03b2-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 USA hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010)","volume":"57","author":"Castanheira","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914000211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914000211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T20:24:12Z","timestamp":1538857452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914000211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0924857914000211"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.01.007","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009\u20132012","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}